GMP IPO Watch
Other Scheme - Index Funds
Bandhan BSE Healthcare Index Fund
Regular Plan · Growth · Bandhan Mutual Fund
Risk: Very High Risk
52W Low ₹9.32 29 Jan 2026
52W High ₹11.85 23 Sept 2026
₹11.5924
NAV as of 4 Nov 2026
+1.01% day change
Other Plans of This Fund
ISININF194KB1IR4
Scheme Code152843
StructureOpen Ended Schemes
Fund HouseBandhan AMC Limited
AUM (avg. July - September 2026)₹10.02 Cr
Expense Ratio (as of 3 Nov 2026)1.14%
Min. InvestmentRs. 1,000/- and in multiples of Re. 1/- thereafter
Inception Date21 Aug 2024
BenchmarkBSE Healthcare TRI
Portfolio Turnover17.54%
NFO Period21st August 2024 – 3rd September 2024
Returns
1Y
+13.22%
Since Inception
+7.26%
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +3.33% | +3.19% | 161 of 283 |
| 1M | +2.28% | +2.85% | 146 of 283 |
| 3M | +0.35% | -2.37% | 74 of 283 |
| 6M | +12.56% | +1.56% | 6 of 278 |
| YTD | +16.22% | -0.86% | 10 of 283 |
| 1Y | +13.22% | -0.15% | 9 of 263 |
| 2Y | +7.31% | +2.58% | 10 of 193 |
| INCEPTION | +7.26% | — | — |
Ranked among: Other Scheme - Index Funds.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +2.15% | +20.84% | -13.68% | 57% | 22% |
| 6M | +4.47% | +25.84% | -11.79% | 59% | 24% |
| 1Y | +6.18% | +18.16% | -4.73% | 80% | 33% |
| 2Y | +5.94% | +8.35% | +3.30% | 100% | 42% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity100.17%
- Debt0.00%
- Cash-0.17%
- Other0.00%
Market Cap Split
- Large Cap33.33%
- Mid Cap38.51%
- Small Cap28.15%
- Others0.00%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 39.18 | 23.32 |
| P/B | 5.49 | 3.82 |
| Price / Sales | 5.64 | 3.28 |
| Price / Cash Flow | 30.00 | 17.26 |
| Dividend Yield (%) | 0.56 | 1.64 |
Holdings138
Top 5 Stocks34.68%
Top 10 Stocks53.32%
Top 3 Sectors100.17%
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Sun Pharmaceutical | Pharmaceuticals & Biotechnology | 12.36% | -0.59% |
| Divis Laboratories | Pharmaceuticals & Biotechnology | 7.44% | +0.22% |
| Apollo Hospitals | Equity | 5.23% | -0.32% |
| Laurus Labs | Pharmaceuticals & Biotechnology | 4.85% | +0.37% |
| Cipla | Pharmaceuticals & Biotechnology | 4.80% | -0.11% |
| Dr Reddys Laboratories | Pharmaceuticals & Biotechnology | 4.74% | +0.39% |
| Max Healthcare Institute | Equity | 4.33% | -0.29% |
| Torrent Pharmaceuticals | Pharmaceuticals & Biotechnology | 3.56% | -0.80% |
| Lupin | Pharmaceuticals & Biotechnology | 3.11% | -0.13% |
| Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.90% | +0.01% |
| Fortis Healthcare | Equity | 2.52% | -0.38% |
| Glenmark Pharmaceuticals | Pharmaceuticals & Biotechnology | 2.17% | -0.11% |
| Alkem Laboratories | Pharmaceuticals & Biotechnology | 1.90% | -0.02% |
| Zydus Life Science | Pharmaceuticals & Biotechnology | 1.83% | +0.04% |
| Mankind Pharma | Pharmaceuticals & Biotechnology | 1.76% | +0.12% |
View all 141 holdings
| IPCA Laboratories | Pharmaceuticals & Biotechnology | 1.69% | +0.00% |
| Biocon | Pharmaceuticals & Biotechnology | 1.64% | -0.13% |
| Gland Pharma | Pharmaceuticals & Biotechnology | 1.45% | +0.05% |
| Sai Life Sciences | Pharmaceuticals & Biotechnology | 1.30% | +0.09% |
| Krishna Institute of Medical Sciences | Equity | 1.25% | +0.10% |
| Aster DM Quality Care | Equity | 1.18% | -0.04% |
| Neuland Laboratories | Pharmaceuticals & Biotechnology | 1.16% | -0.05% |
| Wockhardt | Pharmaceuticals & Biotechnology | 1.10% | +0.14% |
| Acutaas Chemicals | Pharmaceuticals & Biotechnology | 1.06% | +0.06% |
| Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.02% | +0.08% |
| Dr. Lal Path Labs | Equity | 0.97% | +0.05% |
| Abbott | Pharmaceuticals & Biotechnology | 0.87% | +0.06% |
| Piramal Pharma | Pharmaceuticals & Biotechnology | 0.81% | -0.01% |
| Narayana Hrudayalaya | Equity | 0.78% | -0.03% |
| Shilpa Medicare | Pharmaceuticals & Biotechnology | 0.77% | +0.09% |
| Granules | Pharmaceuticals & Biotechnology | 0.77% | +0.04% |
| Global Health | Equity | 0.76% | -0.02% |
| Onesource Specialty Pharma | Pharmaceuticals & Biotechnology | 0.75% | +0.03% |
| GlaxoSmithKline Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.71% | -0.05% |
| Rubicon Research | Pharmaceuticals & Biotechnology | 0.67% | +0.32% |
| Anthem Biosciences | Pharmaceuticals & Biotechnology | 0.58% | -0.19% |
| Jubilant Pharmova | Pharmaceuticals & Biotechnology | 0.52% | +0.09% |
| Emcure Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.51% | +0.12% |
| Strides Pharma Science | Pharmaceuticals & Biotechnology | 0.47% | +0.05% |
| Natco Pharma | Pharmaceuticals & Biotechnology | 0.47% | +0.00% |
| Cohance Lifesciences | Pharmaceuticals & Biotechnology | 0.45% | +0.00% |
| Vijaya Diagnostic Centre | Equity | 0.45% | +0.00% |
| Syngene International | Equity | 0.44% | -0.03% |
| Marksans Pharma | Pharmaceuticals & Biotechnology | 0.43% | +0.01% |
| Rainbow Childrens Medicare | Equity | 0.42% | -0.02% |
| Poly Medicure | Equity | 0.40% | -0.01% |
| Indegene | Equity | 0.38% | -0.01% |
| Eris Lifesciences | Pharmaceuticals & Biotechnology | 0.38% | -0.11% |
| Pfizer | Pharmaceuticals & Biotechnology | 0.37% | -0.06% |
| Metropolis Healthcare | Equity | 0.36% | -0.02% |
| Caplin Point Laboratories | Pharmaceuticals & Biotechnology | 0.34% | +0.03% |
| Aarti Pharma Labs | Pharmaceuticals & Biotechnology | 0.31% | +0.04% |
| Jupiter Life Line Hospital | Equity | 0.30% | -0.04% |
| Concord Biotech | Pharmaceuticals & Biotechnology | 0.29% | -0.01% |
| Bliss GVS Pharma | Pharmaceuticals & Biotechnology | 0.29% | +0.04% |
| Alembic Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.29% | +0.01% |
| Procter & Gamble Health | Pharmaceuticals & Biotechnology | 0.28% | +0.00% |
| Yatharth Hospital | Equity | 0.28% | +0.02% |
| Triparty Repo TRP_011026 | Reverse Repo / TREPS | 0.28% | — |
| Morepen Laboratories | Pharmaceuticals & Biotechnology | 0.27% | +0.04% |
| Alivus Life Sciences | Pharmaceuticals & Biotechnology | 0.27% | +0.01% |
| Corona Remedies | Pharmaceuticals & Biotechnology | 0.25% | +0.17% |
| AstraZeneca Pharma | Pharmaceuticals & Biotechnology | 0.24% | -0.03% |
| Viyash Scientific | Pharmaceuticals & Biotechnology | 0.23% | -0.02% |
| Dr. Agarwal's Health Care | Equity | 0.23% | -0.01% |
| Healthcare Global Enterprises | Equity | 0.22% | -0.02% |
| Senores Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.22% | +0.00% |
| Thyrocare Technologies | Equity | 0.21% | -0.02% |
| Akums Drugs & Pharma | Pharmaceuticals & Biotechnology | 0.18% | +0.02% |
| Sanofi | Pharmaceuticals & Biotechnology | 0.17% | +0.00% |
| Kovai Medical Center Hospital | Equity | 0.17% | +0.00% |
| Sanofi Consumer Healthcare | Pharmaceuticals & Biotechnology | 0.16% | -0.01% |
| Supriya Lifescience | Pharmaceuticals & Biotechnology | 0.15% | +0.02% |
| Nephrocare Health Services | Equity | 0.15% | +0.06% |
| Suven Life Sciences | Equity | 0.15% | -0.03% |
| IOL Chemicals & Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.15% | +0.01% |
| Blue Jet Healthcare | Pharmaceuticals & Biotechnology | 0.13% | +0.01% |
| Park Medi World | Equity | 0.13% | +0.03% |
| Ind Swift Laboratories | Pharmaceuticals & Biotechnology | 0.12% | — |
| Sun Pharma Advanced Research Co | Pharmaceuticals & Biotechnology | 0.12% | +0.00% |
| Innova Captab | Pharmaceuticals & Biotechnology | 0.12% | +0.01% |
| Solara Active Pharma Sciences | Pharmaceuticals & Biotechnology | 0.11% | +0.02% |
| Artemis Medicare Services | Equity | 0.11% | +0.01% |
| Kwality Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.10% | +0.01% |
| FDC | Pharmaceuticals & Biotechnology | 0.10% | +0.00% |
| Indraprastha Medical Corporation | Equity | 0.10% | +0.00% |
| Aarti Drugs | Pharmaceuticals & Biotechnology | 0.10% | +0.01% |
| Orchid Pharma | Pharmaceuticals & Biotechnology | 0.10% | +0.01% |
| SMS Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.09% | +0.02% |
| Novartis | Pharmaceuticals & Biotechnology | 0.09% | +0.02% |
| Venus Remedies | Pharmaceuticals & Biotechnology | 0.09% | — |
| Shukra Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.08% | — |
| Advanced Enzyme Tech | Pharmaceuticals & Biotechnology | 0.08% | +0.00% |
| RPG Life Sciences | Pharmaceuticals & Biotechnology | 0.08% | +0.01% |
| Gujarat Themis Biosyn | Pharmaceuticals & Biotechnology | 0.08% | +0.00% |
| Gufic BioSciences | Pharmaceuticals & Biotechnology | 0.07% | +0.00% |
| Syncom Formulations | Pharmaceuticals & Biotechnology | 0.07% | +0.01% |
| Unichem Laboratories | Pharmaceuticals & Biotechnology | 0.07% | +0.00% |
| Krsnaa Diagnostics | Equity | 0.06% | +0.00% |
| Dishman Carbogen Amcis | Pharmaceuticals & Biotechnology | 0.06% | -0.01% |
| Fredun Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.06% | — |
| Indoco Remedies | Pharmaceuticals & Biotechnology | 0.06% | +0.00% |
| Vimta Labs | Equity | 0.06% | +0.00% |
| Anlon Healthcare | Pharmaceuticals & Biotechnology | 0.05% | — |
| 3B BlackBio DX | Equity | 0.05% | +0.01% |
| Windlas Biotech | Pharmaceuticals & Biotechnology | 0.05% | +0.00% |
| Fischer Medical Ventures | Equity | 0.05% | +0.00% |
| Hester Biosciences | Pharmaceuticals & Biotechnology | 0.05% | +0.00% |
| Hikal | Pharmaceuticals & Biotechnology | 0.05% | +0.00% |
| Amrutanjan Health Care | Pharmaceuticals & Biotechnology | 0.05% | — |
| Kopran | Pharmaceuticals & Biotechnology | 0.05% | +0.01% |
| Suraksha Diagnostic | Equity | 0.04% | +0.00% |
| Sigachi Industries | Pharmaceuticals & Biotechnology | 0.04% | -0.01% |
| KMC Speciality Hospitals | Equity | 0.04% | +0.01% |
| Sai Parenteral's | Pharmaceuticals & Biotechnology | 0.04% | — |
| Dr. Agrawals Eye Hospital | Equity | 0.04% | +0.00% |
| Panacea Biotec | Pharmaceuticals & Biotechnology | 0.04% | +0.00% |
| Lincoln Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.04% | +0.00% |
| Fermenta Biotech | Pharmaceuticals & Biotechnology | 0.03% | +0.00% |
| Tarsons Products | Equity | 0.03% | +0.00% |
| NGL Fine Chem | Pharmaceuticals & Biotechnology | 0.03% | — |
| GPT Healthcare | Equity | 0.03% | +0.00% |
| Bajaj HealthCare | Pharmaceuticals & Biotechnology | 0.03% | +0.01% |
| Jagsonpal Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.03% | +0.00% |
| Gujarat Kidney and Super Speciality | Equity | 0.02% | +0.00% |
| Wanbury | Pharmaceuticals & Biotechnology | 0.02% | -0.01% |
| Shalby | Equity | 0.02% | -0.01% |
| Laxmi Dental | Equity | 0.02% | +0.00% |
| Themis Medicare | Pharmaceuticals & Biotechnology | 0.02% | +0.00% |
| One Global Service Provider | Equity | 0.02% | — |
| Kilitch Drugs | Pharmaceuticals & Biotechnology | 0.02% | — |
| Medicamen Biotech | Pharmaceuticals & Biotechnology | 0.02% | — |
| Anuh Pharma | Pharmaceuticals & Biotechnology | 0.02% | +0.01% |
| Gaudium IVF & Women Health | Equity | 0.01% | — |
| Fabtech Technologies | Equity | 0.01% | +0.00% |
| Ambalal Sarabhai Enterprises | Pharmaceuticals & Biotechnology | 0.01% | — |
| TAKE | Equity | 0.01% | — |
| Gennex Laboratories | Pharmaceuticals & Biotechnology | 0.01% | — |
| Medico Remedies | Pharmaceuticals & Biotechnology | 0.00% | — |
| Cash Margin - CCIL | Net Current Assets | 0.00% | — |
| Net Current Assets | Net Current Assets | -0.45% | — |
Sector Allocation · Sep 2026
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 13.51 | 12.38 | High Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.47 | -0.51 | Above Average |
| 3Y | 0.07 | 0.26 | Below Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 1.46 | 12.56 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Tracking Difference
1Y-4.12%
Since Inception-2.47%
Versus BSE Health Care - TRI, as of Sep 2026.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
ICICI Prudential Nifty Pharma Index Fund
Direct Plan · IDCW
|
+22.53% | +22.50% | — | +21.44% |
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
Direct Plan · Growth
|
+20.88% | +21.50% | +14.91% | +16.74% |
|
Tata Nifty Capital Markets Index Fund
Direct Plan · Growth Option
|
+19.89% | — | — | +21.71% |
|
Motilal Oswal Nifty Capital Market Index Fund
Regular Plan · Growth
|
+19.31% | — | — | +16.06% |
|
Motilal Oswal S&P 500 Index Fund
Direct Plan · GROWTH
|
+18.19% | +25.74% | +16.20% | +20.46% |
|
Tata Nifty MidSmall Healthcare Index Fund
Regular Plan · IDCW Payout Option
|
+17.24% | — | — | +17.73% |
|
Motilal Oswal Nifty MidSmall Healthcare Index Fund
Regular Plan · Growth
|
+17.19% | — | — | +11.55% |
|
ICICI Prudential NASDAQ 100 Index Fund
Regular Plan · Growth
|
+15.21% | +27.99% | +16.74% | +17.49% |
|
Motilal Oswal Nifty India Defence Index Fund
Regular Plan · Growth
|
+13.06% | — | — | +4.19% |
|
DSP Nifty Healthcare Index Fund
Regular Plan · Growth
|
+12.65% | — | — | +12.61% |
More From Bandhan AMC Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
BANDHAN INNOVATION FUND
Direct Plan · Growth
|
+14.35% | — | — | +20.03% |
|
Bandhan US Treasury Bond 0-1 year specific Debt Passive FOF
Direct Plan · IDCW
|
+10.64% | +8.91% | — | +8.51% |
|
Bandhan Gilt Fund
Direct Plan · Growth
|
+7.31% | +8.25% | +6.45% | +8.58% |
|
Bandhan CRISIL-IBX Financial Services 3-6 Months Debt Index Fund
Direct Plan · Growth
|
+6.77% | — | — | +7.03% |
|
BANDHAN Dynamic Term Fund
Direct Plan · Growth
|
+6.71% | +7.89% | +6.20% | +8.15% |
|
Bandhan Money Market Fund
Direct Plan · Periodic IDCW
|
+6.56% | +7.39% | +6.77% | +4.70% |
|
BANDHAN LIQUID Fund
Direct Plan · Periodic IDCW
|
+6.46% | +6.88% | +6.41% | +1.51% |
|
BANDHAN Arbitrage Fund
Direct Plan · Growth
|
+6.43% | +7.26% | +6.79% | +6.91% |
|
BANDHAN ULTRA SHORT TERM FUND
Direct Plan · Periodic IDCW
|
+6.43% | +7.19% | +6.61% | +4.33% |
|
BANDHAN MID CAP FUND
Direct Plan · Growth
|
+6.35% | +18.05% | — | +17.81% |
About This Scheme
Investment Objective
The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in the underlying securities in the same proportion, subject to tracking error. The BSE Healthcare Index will track the performance of companiesthat are part of BSE AllCap belonging to the Healthcare sector.
Stated Asset Allocation
Securities belonging to the Bandhan BSE Healthcare Index (including stock and index derivatives) - 95% - 100% Debt & Money Market instruments - 0%- 5%
Exit Load
• 0.25% - if redeemed on or before 15 days from the allotment date. • Nil – if redeemed after 15 days from the allotment date
Fund Managers
FM 1 - Mr. Abhishek Jain, FM 2 - Mr. Mayuresh Nagvekar
FM 1 - Primary, FM 2 - Comanage
Official Documents
Scheme Information Document (PDF)
Scheme Summary (PDF)
Scheme Summary (XLS)
Bandhan AMC Limited website
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.